Nan Fung Group Holdings Ltd
Annual return
—
SPY
—
Alpha
—
Invested
$242.5M
Holdings
24
Trades YTD
0
Performance · Fund vs SPY
Cumulative return · quarterly snapshotsIn development
Quarterly performance not yet computed for this fund.
The metrics pipeline computes return / SPY benchmark / alpha per quarter from this fund's 13F holdings and the SPY adj-close. It hasn't produced enough quarters here yet — the chart fills in automatically once at least two are on record.
Top holdings · current snapshot
Source: 13F-HR01
$EVMN
EVOMMUNE INC
Held since at least Q1 2024
28.4%
02
$MPLT
MAPLIGHT THERAPEUTICS INC
Held since at least Q1 2024
16.9%
03
$LBRX
LB PHARMACEUTICALS INC
Q4 2025: Exited (was 300.0k shares)
13.3%
04
$INCY
INCYTE CORP
Q4 2025: Exited (was 59.0k shares)
4.3%
05
$ONC
BEONE MEDICINES LTD
Q4 2025: Exited (was 15.7k shares)
4.0%
06
$OCS
OCULIS HOLDING AG
Q4 2025: Exited (was 514.7k shares)
4.0%
07
$RYTM
RHYTHM PHARMACEUTICALS INC
Q4 2025: Exited (was 49.1k shares)
3.7%
08
$CELC
CELCUITY INC
Held since at least Q1 2024
2.8%
09
$ASND
ASCENDIS PHARMA A/S
Q4 2025: Exited (was 13.6k shares)
2.7%
10
$PCOR
PROCORE TECHNOLOGIES INC
Held since at least Q1 2024
2.6%
Recent trades · Last 90 days
No Form 4 / 13D / 13G trade events on file in the recent window. 13F filers report position snapshots quarterly rather than per-trade events, so this section is most useful for managers who also file Form 4 or 13D/G.
Source data: SEC EDGAR · 13F-HR filings · Last refreshed 06:13 UTC.